Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
alferminogene tadenovec (1 trial)
Angina Pectoris (Phase 3)
Angina, Stable (Phase 3)
Coronary Artery Disease (Phase 3)
Ischemia (Phase 3)
Myocardial Ischemia (Phase 3)
Trials (1 total)
Trial APIs (1 total)